BerganKDV Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.31K Hold
6
﹤0.01% 726
2023
Q1
$1.31K Hold
6
﹤0.01% 880
2022
Q4
$1.25K Hold
6
﹤0.01% 852
2022
Q3
$1K Sell
6
-11
-65% -$2.5K ﹤0.01% 920
2022
Q2
$4K Hold
17
﹤0.01% 742
2022
Q1
$4K Hold
17
﹤0.01% 770
2021
Q4
$4K Hold
17
﹤0.01% 829
2021
Q3
$4K Hold
17
﹤0.01% 788
2021
Q2
$4K Hold
17
﹤0.01% 737
2021
Q1
$3K Hold
17
﹤0.01% 749
2020
Q4
$4K Buy
17
+11
+183% +$2.19K ﹤0.01% 703
2020
Q3
$1K Sell
6
-4
-40% -$739 ﹤0.01% 853
2020
Q2
$2K Buy
+10
New +$1.64K ﹤0.01% 781

Other funds holding RMD

BerganKDV Wealth Management's RMD Position: Q2 2023 in Review

BerganKDV Wealth Management held its ResMed (RMD) position steady in Q2 2023 at 6 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #726.

BerganKDV Wealth Management first reported a position in RMD in Q2 2020 and has held it in 13 quarters since. The position peaked at $4K in Q2 2022. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

  • BerganKDV Wealth Management held 6 shares of ResMed worth $1.31K as of Q2 2023.
  • BerganKDV Wealth Management left its ResMed share count unchanged in Q2 2023.
  • ResMed made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #726 holding.
  • BerganKDV Wealth Management first reported a position in ResMed in Q2 2020 and has held it in 13 quarters since.
  • BerganKDV Wealth Management's ResMed position peaked at $4K in Q2 2022.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.